John Leonard, MD John Leonard, MD, of Weill Cornell Medicine, New York City, has built a devoted following for his “Leonard List” — previews of research to be presented at annual American Society of Hematology (ASH) meetings that are held every December. For example, in November 2024, in the days leading up to ASH 2025, … Read more
A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and neck cancer who cannot receive the standard chemotherapy drug cisplatin. Because cisplatin can damage the kidneys and cochlea, patients who have kidney problems or hearing loss are usually not candidates to take the drug. … Read more
People with vasculitis may need at least three or four vaccinations for COVID-19 before they start to show an immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, new research has suggested. In a longitudinal retrospective study, serum antibody neutralization against the Omicron variant of the virus and its descendants was found to … Read more
TOPLINE: The use of valaciclovir as prophylaxis prevents herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE) receiving anifrolumab treatment, with no cases of zoster reported during the follow-up period in patients receiving valaciclovir. METHODOLOGY: Anifrolumab, a human monoclonal antibody binding to type I interferon receptor subunit 1, increases the risk for HZ in … Read more